GWM
VRTX icon

GK Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

GK Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Buy
+922
New +$409K 0.24% 108
2026
Q1 		– Sell
-732
Closed -$332K – 213
2025
Q4 		$332K Sell
732
-35
-5% -$15.1K 0.22% 114
2025
Q3 		$300K Buy
767
+78
+11% +$32.6K 0.22% 109
2025
Q2 		$307K Buy
+689
New +$318K 0.28% 96

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

GK Wealth Management's VRTX Position: Q2 2026 in Review

GK Wealth Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 922 shares worth $458K. The stake represents 0.24% of the portfolio and ranks #108 among its holdings. This is a return to the name: GK Wealth Management previously reported a position in VRTX as recently as Q4 2025.

GK Wealth Management first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. 252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • GK Wealth Management held 922 shares of Vertex Pharmaceuticals worth $458K as of Q2 2026.
  • Vertex Pharmaceuticals was a new GK Wealth Management position in Q2 2026.
  • Vertex Pharmaceuticals made up 0.24% of GK Wealth Management's portfolio in Q2 2026, its #108 holding.
  • GK Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on GK Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.